Clinical trials
Phase 1 COVID-19 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Oxford | 3 |
| AstraZeneca | 2 |
| Codagenix, Inc | 2 |
| Imperial College London | 2 |
| Aligos Therapeutics | 1 |
| BerGenBio ASA | 1 |
| Gritstone bio, Inc. | 1 |
| Hampshire Hospitals NHS Foundation Trust | 1 |
| Hoffmann-La Roche | 1 |
| Hvivo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 21 |
| Coronavirus Infections | 5 |
| Influenza, Human | 2 |
| Acute Lung Injury | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Cardiovascular Diseases | 1 |
| Glioblastoma | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Melanoma | 1 |
| Mesothelioma, Malignant | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.